We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Malaria Diagnostic Test Evaluated in Asia

By LabMedica International staff writers
Posted on 03 Jan 2013
Rapid diagnostic tests (RDT) for malaria have been brought into field operations to supplement and in some cases replace the gold standard of light microscopy. More...


Although attempts have been made to augment or even replace microscopic diagnosis of malaria with enzyme-linked immunosorbent assays (ELISA), real time, and conventional polymerase chain reactions (PCR), these are not feasible in the field.

Scientists at the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B; Dhaka, Bangladesh) collected whole blood samples from 372 febrile patients referred for malaria diagnosis by clinicians from May 2009 to December 2010. The samples were assayed by a newly available RDT and were compared to microscopy adjusted with nested PCR as the gold standard. DNA extraction for the PCR was prepared using QiaAmp blood mini-kit (Qiagen; Hilden, Germany) from preserved whole blood. Other PCR reagents were obtained from New England BioLabs Inc.; Ipswich, MA, USA).

The RDT device evaluated was the Onsite (Pf/Pan) RDT produced by CTK Biotech Inc. (San Diego, CA, USA) which has the ability to detect Pan-specific lactate dehydrogenase (pLDH) and Plasmodium falciparum specific histidine-rich protein 2 (HRP-2). Of these 372 patients, 229 (61.6%) tested positive for malaria infection detected by microscopy and nested PCR. The OnSite (Pf/Pan) RDT was 94.2% sensitive and 99.5% specific for P. falciparum diagnosis and 97.3% sensitive and 98.7% specific for P. vivax diagnosis. Sensitivity varied with differential parasite count for both malaria species. The highest sensitivity was observed in febrile patients with parasitemias that ranged from 501 to 1,000 parasites/µL regardless of the Plasmodium species.

The authors concluded that the OnSite (Pf/Pan) RDT, a lateral flow chromatographic immunoassay, performed satisfactorily in standard laboratory conditions. It can be utilized for diagnosis of symptomatic malaria as well as to discriminate falciparum malaria infection from vivax malaria in endemic areas and during outbreaks. However, a field evaluation is required to assess its applicability for routine diagnosis in resource-limited settings where the practicability of microscopy is limited. The study was published on December 12, 2012, in the Malaria Journal.

Related Links:
International Centre for Diarrheal Disease Research Bangladesh
Qiagen
New England BioLabs Inc.




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
New
Clinical Chemistry System
P780
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Pathology

view channel
Image: An adult fibrosarcoma case report has shown the importance of early diagnosis and targeted therapy (Photo courtesy of Sultana and Sailaja/Oncoscience)

Accurate Pathological Analysis Improves Treatment Outcomes for Adult Fibrosarcoma

Adult fibrosarcoma is a rare and highly aggressive malignancy that develops in connective tissue and often affects the limbs, trunk, or head and neck region. Diagnosis is complex because tumors can mimic... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.